Amylyx Pharmaceuticals, Inc.
AMLX
Revenue
0.00
0.000.00%
3 Months ChangeAssets
332.65M
▼-30.10M▼-8.30%
3 Months ChangeLiabilities
27.39M
▼-3.36M▼-10.93%
3 Months ChangeFree Cash Flow
-39.84M
▼-39.28M▼-7064.57%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-03
Form 8-K
ID: 0001193125-26-086629
2026-01-08
Form 8-K
ID: 0001193125-26-006991
2025-11-06
Form 10-Q
ID: 0001193125-25-268059
2025-11-06
Form 8-K
ID: 0001193125-25-268043
2025-09-10
Form 8-K
ID: 0001193125-25-200159
2025-08-27
Form 8-K
ID: 0001193125-25-189109
2025-08-07
Form 10-Q
ID: 0001193125-25-174948
2025-08-07
Form 8-K
ID: 0000950170-25-104546
2025-06-05
Form 8-K
ID: 0001193125-25-135860
2025-05-08
Form 10-Q
ID: 0000950170-25-066363